Manitou Gold Announces Appointment of New Director, Completes Property Acquisition and Share Issuances
SUDBURY, Ontario, June 30, 2020 (GLOBE NEWSWIRE) — Manitou Gold Inc. (TSXV: MTU) (the “Company” or “Manitou”) is pleased to […]
Stein Mart, Inc. Reports First Quarter 2020 Results and Provides Update on COVID-19 Response
First quarter net loss of $(65.7) million or $(1.38) per share compared to net income of $4.0 million or $0.08 […]
T2 Biosystems Announces U.S. Launch of COVID-19 Diagnostic Test
LEXINGTON, Mass., June 30, 2020 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, […]
Society for Vascular Surgery (SVS) Issues Guidance on Competence Recommendations for TCAR
New Guidelines Consistent with Silk Road Medical Certification ProcessSUNNYVALE, Calif., June 30, 2020 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: […]
Exela Technologies, Inc. Reports First Quarter 2020 Results
Files Form 10-Q for the Three Months Ended March 31, 2020Conference Call to Discuss Results Scheduled for June 30, 2020 […]
PFSweb Announces Results of 2020 Annual Meeting of Stockholders and Joins Russell 3000® Index
ALLEN, Texas, June 30, 2020 (GLOBE NEWSWIRE) — PFSweb, Inc. (NASDAQ: PFSW), a global commerce services company, held its Annual […]
Aqua Metals Meets Nasdaq Compliance Requirements for Continued Listing
MCCARRAN, Nev., June 30, 2020 (GLOBE NEWSWIRE) — Aqua Metals, Inc. (NASDAQ: AQMS) (“Aqua Metals” or the “Company”), which is […]
Kimball Electronics Announces Internal Promotions, Executive Retirements
JASPER, Ind., June 30, 2020 (GLOBE NEWSWIRE) — Kimball Electronics, Inc. (NASDAQ: KE), (the “Company”), today announced two new internal […]
Revolution Medicines Reports New Application of Tri-Complex Modality for “Undruggable” Protein Targets and Announces License to Ginkgo Bioworks to Explore Potential Use Against Novel Coronavirus
REDWOOD CITY, Calif. and BOSTON, June 30, 2020 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company […]
Eyenovia Resumes Recruitment of Phase III CHAPERONE Study for Progressive Myopia
NEW YORK, June 30, 2020 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a […]
